Top Tweets for #Exscel
CV outcomes with #exenatide in #T2DM according to ejection fraction: Post-hoc analysis of the Exenatide Study of CV Event Lowering (#EXSCEL) trial
@JavedButler1 @FaiezZANNAD #MiltonPacker
https://t.co/EiTLvfEpF0
@ESC_Journals #EJHF @HanCardiomd @GiuseppeGalati_ @AmrAbdin10

CV outcomes with exenatide in
type 2 diabetes according to EF
#EXSCEL trial evaluating the effects of once-weekly exenatide (EQW) 🆚 placebo on CV outcomes according to baseline LVEF
👥4749 had LVEF available at baseline; 10% LVEF<40%, 90%with LVEF≥40%.
💉Exenatide/sem👇
👉🚫No significant treatment-by-LVEF interactions were observed for MACE, CV💀 or all-cause mortality
👉The risk of 🏥HF was also modified by baseline NYHA class (NYHA class III/IV)
📁 https://t.co/eMMjijEs7k @ESC_Journals

One other issue: In RCTs designed to maintain glycemic equipoise, unbalanced open-label drop-in of SGLT2i & GLP-1RA in PBO may bias towards the null
Drop-in is common & methods available to tease apart its contribution; shown in elegant #EXSCEL analysis:
https://t.co/7MucrbRBNo
I've been thinking about and re-reviewing VERTIS-CV results and am a bit perplexed: it wasn't just one "miss" that was explainable in the context of random chance or empa effect, there were multiple divergent results compared to prior SGLT2i CVOTs (thread)
The #EXSCEL study assessed effects of exenatide on CV outcomes, but aimed for glycemic equipoise. What was impact of open-label drop-in of glucose-lowering meds? Learn more: https://t.co/jDq5QbqcXn #AHAJournals @UniofOxford

Fascinating.
Now 3 GLP-1RA CVOTs to show MACE benefits overall...except in pts w/ established HF. Consistent data from #EXSCEL by @FudimMarat & @robmentz in @CircAHA
Should antihyperglycemic Rx recs be separated for those w/ ASCVD vs. those w/ HF? @JavedButler1 @ShahzebKhanMD
Parsing MACE Results for Semaglutide #T2D (SUSTAIN-6 and PIONEER-6) across varying cardiovascular risk. Reduction of stroke stands out. https://t.co/VZQ8o9WAST

In #EXSCEL, the use of once-weekly exenatide in pts with or without #HF was well tolerated, but the benefits of reduction in all-cause death and first HF hospitalization were attenuated in pts with baseline HF https://t.co/sSGebPbcUz #AHAJournals @FudimMarat @robmentz @DCRINews

(NEJM) Exenatida semanal no es superior a placebo en la prevención de eventos CV en pac con DM2 https://t.co/UnRMCcaIAG ECA #EXSCEL
@dr_kevinlee Injection devices were too scary!
Last Seen Hashtags on Sotwe
pyjama
Seen from Spain
incebelli
Seen from Turkey
randomchat
Seen from United States
goonette
Seen from United States
HollyHalston
Seen from India
tamannahot
Seen from India
MGAI ()video*****************************************
Seen from Argentina
Diaperboy
Seen from Israel
disinipot
Seen from United States
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers



































